WIPOS Speaker

Chad Lewis

  • K36 Therapeutics
  • USA

Synthetic Route Development of a Commercial Active Pharmaceutical Ingredient

  • University of Alberta (B.Sc. Chemistry)
  • Yale University (Ph.D. with Scott Miller)
  • The Scripps Research Institute (Postdoc with Phil Baran)
  • 2010 – Assistant Professor, Cornell University
  • 2015 – Pfizer Process Chemistry
  • 2021 – K36 Therapeutics
  • Research Interests: total synthesis, asymmetric catalysis, natural products, process.
Back to All Speakers